Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Receivables (2016 - 2025)

Icu Medical's Receivables history spans 17 years, with the latest figure at $180.5 million for Q4 2025.

  • For the quarter ending Q4 2025, Receivables fell 1.27% year-over-year to $180.5 million, compared with a TTM value of $180.5 million through Dec 2025, down 1.27%, and an annual FY2025 reading of $180.5 million, down 1.27% over the prior year.
  • Receivables for Q4 2025 was $180.5 million at Icu Medical, down from $191.5 million in the prior quarter.
  • The five-year high for Receivables was $216.6 million in Q4 2022, with the low at $105.9 million in Q4 2021.
  • Average Receivables over 5 years is $165.7 million, with a median of $166.6 million recorded in 2023.
  • Year-over-year, Receivables plummeted 39.26% in 2021 and then surged 104.56% in 2022.
  • Tracing ICUI's Receivables over 5 years: stood at $105.9 million in 2021, then skyrocketed by 104.56% to $216.6 million in 2022, then decreased by 25.41% to $161.6 million in 2023, then increased by 13.16% to $182.8 million in 2024, then dropped by 1.27% to $180.5 million in 2025.
  • Per Business Quant, the three most recent readings for ICUI's Receivables are $180.5 million (Q4 2025), $191.5 million (Q3 2025), and $179.5 million (Q2 2025).